Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection.

Saved in:
Bibliographic Details
Title: Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection.
Authors: Cook JD; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Hooey PB; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada., Salazar KC; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Clark JR; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Jain U; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada., Fernando C; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada., Harvey H; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada., Cervantes A; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Omagari S; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Blankstein U; Department of Surgery, McMaster University, Hamilton, Ontario, Canada., Kropinski AM; Department of Pathobiology, University of Guelph, Ontario, Canada., Davidson AR; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada., Maxwell KL; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada., Burrows LL; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada., Terwilliger AL; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Maresso AW; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., German GJ; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Unity Health Toronto, Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada. Electronic address: Gregory.German@unityhealth.to.
Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2025 Dec; Vol. 66 (6), pp. 107613. Date of Electronic Publication: 2025 Sep 08.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40930191
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cook+JD%22">Cook JD</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hooey+PB%22">Hooey PB</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Salazar+KC%22">Salazar KC</searchLink>; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Clark+JR%22">Clark JR</searchLink>; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Jain+U%22">Jain U</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Fernando+C%22">Fernando C</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Harvey+H%22">Harvey H</searchLink>; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Cervantes+A%22">Cervantes A</searchLink>; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Omagari+S%22">Omagari S</searchLink>; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Blankstein+U%22">Blankstein U</searchLink>; Department of Surgery, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Kropinski+AM%22">Kropinski AM</searchLink>; Department of Pathobiology, University of Guelph, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Davidson+AR%22">Davidson AR</searchLink>; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Maxwell+KL%22">Maxwell KL</searchLink>; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Burrows+LL%22">Burrows LL</searchLink>; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Terwilliger+AL%22">Terwilliger AL</searchLink>; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Maresso+AW%22">Maresso AW</searchLink>; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22German+GJ%22">German GJ</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Unity Health Toronto, Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada. Electronic address: Gregory.German@unityhealth.to.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111860%22">International journal of antimicrobial agents</searchLink> [Int J Antimicrob Agents] 2025 Dec; Vol. 66 (6), pp. 107613. <i>Date of Electronic Publication: </i>2025 Sep 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Case Reports
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9111860 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7913 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209248579%22">09248579 </searchLink><i>NLM ISO Abbreviation: </i>Int J Antimicrob Agents <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40930191
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ijantimicag.2025.107613
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 107613
    Titles:
      – TitleFull: Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cook JD
      – PersonEntity:
          Name:
            NameFull: Hooey PB
      – PersonEntity:
          Name:
            NameFull: Salazar KC
      – PersonEntity:
          Name:
            NameFull: Clark JR
      – PersonEntity:
          Name:
            NameFull: Jain U
      – PersonEntity:
          Name:
            NameFull: Fernando C
      – PersonEntity:
          Name:
            NameFull: Harvey H
      – PersonEntity:
          Name:
            NameFull: Cervantes A
      – PersonEntity:
          Name:
            NameFull: Omagari S
      – PersonEntity:
          Name:
            NameFull: Blankstein U
      – PersonEntity:
          Name:
            NameFull: Kropinski AM
      – PersonEntity:
          Name:
            NameFull: Davidson AR
      – PersonEntity:
          Name:
            NameFull: Maxwell KL
      – PersonEntity:
          Name:
            NameFull: Burrows LL
      – PersonEntity:
          Name:
            NameFull: Terwilliger AL
      – PersonEntity:
          Name:
            NameFull: Maresso AW
      – PersonEntity:
          Name:
            NameFull: German GJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1872-7913
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: International journal of antimicrobial agents
              Type: main
ResultId 1